| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.2 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.2 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |